Pay-for-Delay

EU fines six for pay-for-delay

Servier and Teva have been fined for keeping a generic heart medication off the market.

Study shows swift move from brand to generic drugs

Study shows swift move from brand to generic drugs

By

Researchers say it's not just payers supporting the switch, and all ages appear to be brand agnostic.

Alternative pay-for-delay tactic bogs down FDA

Alternative pay-for-delay tactic bogs down FDA

By

The regulator says serial filers and time restraints are draining resources and staff.

Pay-for-delay deals can go on, Court rules, but not without legal risk

Pay-for-delay deals can go on, Court rules, but not without legal risk

By

The Supreme Court split the baby on "pay-for-delay" settlements, allowing them to continue but opening manufacturers that make them up to lawsuits.

Email Newsletters